InsidersTradesSigma
Track the Lipum AB (publ) stock price and the full directors' dealings record of the company, a listed issuer based in Finland. Shares are quoted on the FI market, under the authority of FIN-FSA. Operating in the Health Care sector, Lipum AB (publ) has recorded 5 reports. The latest transaction was reported on 3 July 2025 (Purchase). Among the most active insiders: Åsa Magnusson. All data is openly available.
5
Insider Decl.
n/a
Thresholds
€170,675
5 ops.
Buy Volume
n/a
n/a
Sell Volume
15Σ signal
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 3 July 2025
Declarations5 total
9,000 shares@ €0.2431100.0% of flowTeckningsoptionISIN SE0015660899FI:A003Q428-1
12,000 shares@ €0.2431100.0% of flowTeckningsoptionISIN SE0015660899FI:A003Q425-1
12,000 shares@ €0.2431100.0% of flowTeckningsoptionISIN SE0015660899FI:A003Q404-1
9,000 shares@ €0.2431100.0% of flowTeckningsoptionISIN SE0015660899FI:A003Q402-1
10,755 shares@ €14.92100.0% of flowAktieISIN SE0015660899FI:A003N409-1
5 of 5 declarations
About Lipum AB (publ)
Lipum AB (publ) is a Swedish biopharmaceutical company focused on developing treatments for inflammatory diseases. It is listed on the Stockholm Stock Exchange (XSTO).